ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Reapplix: Positive Outcome Data of Large Randomized Controlled Trial Presented at American Diabetes Association Scientific Sessions
b3cnewswire
July 04, 2018Reapplix ApS, the regenerative medicine company, initially focussed on chronic wounds, announces that positive outcome data of an independent Randomized Controlled Trial (RCT) of its?LeucoPatch??wound healing platform was presented at the American Diabete
Pharma Sources Insight January 2025
